Delirium in elderly people: an update : Current Opinion in Psychiatry

Secondary Logo

Journal Logo


Delirium in elderly people: an update

Leentjens, Albert FGa; van der Mast, Rose Cb

Author Information
Current Opinion in Psychiatry 18(3):p 325-330, May 2005. | DOI: 10.1097/01.yco.0000165603.36671.97


Purpose of review 

To review recent studies on epidemiology, diagnosis, pathophysiology, treatment and prevention of delirium in elderly people.

Recent findings 

There is no evidence that the clinical picture of delirium in elderly people differs from that in younger patients, although it may run a more chronic course. Diagnosing delirium in demented patients, however, may be difficult due to overlap in symptoms of delirium and dementia. Systematic use of screening and diagnostic instruments may help to diminish the common underdiagnosis of delirium. Delirium is best understood as the result of multiple interacting predisposing and precipitating factors. In the elderly, predisposing factors that make patients more susceptible for delirium include cognitive dysfunction and older age, while important precipitating factors that directly cause delirium are any somatic events and the use of anticholinergic drugs. Delirium has a significant negative prognostic impact on functional and cognitive outcome, as well as on morbidity and mortality. Haloperidol remains the standard treatment for delirium, while there is some evidence for the efficacy of risperidone. Other atypical antipsychotics, as well as cholinesterase inhibitors, have not yet been sufficiently studied. Results of studies on the effectiveness of systematic screening of populations at risk and standardized interventions to prevent delirium have been inconclusive.


In recent years, the emphasis in the approach to delirium has shifted from ad hoc treatment to systematic screening and prevention. Interest has been raised in treatment options other than haloperidol, such as atypical antipsychotics and procholinergic drugs.

© 2005 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid